Physician profile
James E Tearse
NPI 1811099435
$44,820.68
in general payments reported to CMS, 2019-2025
24 companies · $3,357 in 2025
The $3,357 reported for 2025 was more than what 92% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,047 · 2020: $1,301 · 2021: $3,279 · 2022: $7,393 · 2023: $11K · 2024: $9,513 · 2025: $3,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,300 · Food and Beverage: $6,055 · Travel and Lodging: $3,958 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,300 · Royalty Or License: $2,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,300.00 |
| Food and Beverage | $6,055.09 |
| Travel and Lodging | $3,958.22 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,300.00 |
| Royalty Or License | $2,187.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $19,911.63 | 2019-2025 | Cequa, Xelpros, Bromsite |
| Sight Sciences, INC. | $7,008.63 | 2019-2024 | Tearcare System, Omni Surgical System |
| Biotissue Holdings INC. | $3,891.63 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $3,126.51 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Katena Products, INC. (Dba Corza Medical) | $1,875.13 | 2021-2023 | |
| Kala Pharmaceuticals, INC. | $1,619.32 | 2019-2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $1,349.37 | 2024-2025 | |
| Dompe US, INC. | $1,094.09 | 2019-2025 | Oxervate |
| Oyster Point Pharma, INC. | $897.94 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $801.39 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $729.41 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $605.41 | 2019-2021 | |
| Allergan, INC. | $465.37 | 2019-2022 | |
| Alcon Vision LLC | $348.64 | 2019-2025 | Tryptyr, Eysuvis, Clareon |
| Eyevance Pharmaceuticals LLC | $196.29 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $177.94 | 2019-2020 | |
| Harrow Eye, LLC | $165.82 | 2023 | Iheezo |
| Johnson & Johnson Surgical Vision, INC. | $141.43 | 2019-2024 | Tecnis Simplicity |
| Omeros Corporation | $129.61 | 2020 | |
| Shire North American Group INC | $124.01 | 2019 | |
| Mallinckrodt Hospital Products INC. | $70.94 | 2025 | Acthar |
| Ani Pharmaceuticals, INC. | $44.07 | 2023-2024 | Purified Cortrophin Gel |
| Abbvie INC. | $25.00 | 2022 | |
| Akorn, INC. | $21.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tearse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.